Showing results (411-420 of 461) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|March 8, 2014
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialKirit M Ardeshna, Wendi Qian, Paul Smith, et al.
Nature Medicine|September 19, 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Clinical and Translational Science|August 23, 2015
Practice-based Research Network Research Good Practices (PRGPs): Summary of RecommendationsRowena J Dolor, Kimberly Campbell-Voytal, Jeanette Daly, et al.
Cancer Cell|May 3, 2003
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisDaniele Bergamaschi, Milena Gasco, Louise Hiller, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
British Journal of Haematology|May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trialMary Gleeson, Nicholas Counsell, David Cunningham, et al.
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Cancers|July 2, 2021
An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary GlioblastomaColin Watts, Keyoumars Ashkan, Michael D Jenkinson, et al.
The New England Journal of Medicine|June 23, 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's LymphomaPeter Johnson, Massimo Federico, Amy Kirkwood, et al.
British Journal of Haematology|August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trialMary Gleeson, Eliza A Hawkes, David Cunningham, et al.
Pageof 47